STEPHANI SCHUTT: Open Payments
NPI 1386300184 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 51 payments from 12 companies in 2025. Trend: 2023 $45 · 2024 $658 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $273 |
| PFIZER INC. | 22 | $255 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Eisai Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| UCB, Inc. | 1 | $43 |
| Neurelis, Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $31 |
| GE HEALTHCARE | 1 | $30 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $24 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, Symbravo, Leqembi, INGREZZA, Briviact, VALTOCO.
Industry payments across PA — which companies pay providers there.
